大承气汤加味治疗粘连性肠梗阻疗效观察  被引量:8

Treatment of Adhesive Intestinal Obstruction with Dachengqi Decoction

在线阅读下载全文

作  者:赵辉[1] 许炳华[1] 张淳[1] 沈晓明[1] 朱欢欢[1] 吕国强[1] 

机构地区:[1]无锡市第三人民医院胃肠外科,江苏无锡214041

出  处:《辽宁中医药大学学报》2012年第9期182-184,共3页Journal of Liaoning University of Traditional Chinese Medicine

摘  要:目的:观察大承气汤加味在肠梗阻治疗中的疗效。方法:将94例肠梗阻患者分治疗组51例,对照组43例。对照组予西医保守治疗;治疗组在西医治疗基础上予大承气汤加味胃管注入。结果:治疗组总有效率及痊愈率分别为90.2%和68.6%,明显高于对照组的74.4%和41.9%(P<0.05及P<0.01);无效转手术率治疗组明显低于对照组(9.8%vs 25.6%,P<0.01);肛门排气时间治疗组明显短于对照组(40.04±10.72)h vs(53.39±8.08)h,P<0.01;住院时间治疗组明显短于对照组(7.14±1.51)天v(s9.37±1.99)天,P<0.01;治疗72h后,外周血C-反应蛋白(CRP)治疗组明显低于对照组(P<0.01),白细胞计数(WBC)两组无差异(P>0.05)。结论:承气汤加味灌胃结合西医保守治疗在肠梗阻治疗中疗效显著,值得临床推广应用。Objective:To observe the effect of Dachengqi decoction in the treatment of adhesive intestinal obstruction.Methods:94 cases were divided into 2 groups,the control group(43 cases)was treated by conservative treatment and treatment group(51 cases)was treated by routine western medicine conbined with Dachengqi decoction.Results:The total effective rate and cure rate was 90.2% and 68.6% in treatment group,significantly higher than that of control group 74.4% and 41.9%(P0.05 and P0.01);invalid operation rate of the treatment group was significantly lower than control group(9.8% vs 25.6%,P0.01);anal exhaust time of the treatment group was significantly shorter than control group(40.04±10.72)h vs(53.39±8.08)h,P0.01;Length of time in hospital,treatment group was shorter than control group(7.14±1.51)d vs(9.37±1.99)d,P0.01;CRP in treatment group was significantly lower than that of the control group After 72 hours of treatment(P0.01);no difference in WBC of two groups(P0.05).Conclusion:There is significant effect in the treatment of intestinal obstruction by Dachengqi Decoction combined with WM,worthy of further clinical application.

关 键 词:肠梗阻 承气汤加味 胃管注入 C-反应蛋白 

分 类 号:R574.2[医药卫生—消化系统]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象